We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Dr. Laura Abraira del Fresno, Senior researcher, Research Group on Status Epilepticus and Acute Seizures (VHIR)
Stroke is the most frequent cause of epilepsy over 60 years. The present clinical risk factors are not enough to predict which patients are at greater risk of post- stroke epilepsy. Stroke related seizures can be triggered by acute metabolic disturbances secondary to brain damage (early-onset seizures) or appear spontaneously after a latent period of epileptogenesis (late-onset seizures or epilepsy). The epileptogenesis process involves multiple molecular changes that will make the brain tissue capable of generating spontaneous seizures. The role of these molecules after an acute stroke event has not been widely investigated. The study of clinical factors and blood biomarkers would let us deep into the mechanisms of the development of epilepsy and to identify some predictive biomarker. Thus, it will be helpful to investigate future modifying or preventive treatment strategies.
At the presentation we will talk about poststroke epilepsy, about the epileptogenesis process and we will describe the clinical factors and biomarkers present during acute stroke and analyze their association with stroke related seizures. A multimodal panel with both clinical variables and biomarkers would be helpful to identify the patients who are more likely to have either early-onset seizures or post-stroke epilepsy.
Host: Dr. Estevo Santamarina Pérez, Head of group Research Group on Status Epilepticus and Acute Seizures (VHIR)
Online connection: https://gencat.zoom.us/j/98773209663
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.